CIK 0001275187 · Accelerated filer
ANGIODYNAMICS INC
Sign in to watch- Ticker
- ANGO
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- May 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 113146460
- Phone
- 5187981215
- Business address
- 14 PLAZA DRIVE, LATHAM, NY, 12110
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $310,688
- in 1 filing
Net −$310,688. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-08-12 | Clemmer James C President and CEO | Option exercise · Performance Right | −34,938 | 0 | ||
| 2021-08-12 | Trowbridge Stephen A EVP and CFO | Option exercise | +10,946 | 79,254 | ||
| 2021-08-12 | Trowbridge Stephen A EVP and CFO | Shares withheld for taxes | −4,173 | $27.29 | $114K | 75,081 |
| 2021-08-12 | Trowbridge Stephen A EVP and CFO | Option exercise · Performance Right | −9,437 | 0 | ||
| 2021-08-12 | Helsel Dave SVP Global Operations and R&D | Option exercise | +11,406 | 33,228 | ||
| 2021-08-12 | Helsel Dave SVP Global Operations and R&D | Shares withheld for taxes | −3,347 | $27.29 | $91K | 29,881 |
| 2021-08-12 | Helsel Dave SVP Global Operations and R&D | Option exercise · Performance Right | −9,834 | 0 | ||
| 2021-08-12 | Helsel Dave SVP Global Operations and R&D | Option exercise | +2,685 | 24,507 | ||
| 2021-08-12 | Helsel Dave SVP Global Operations and R&D | Shares withheld for taxes | −788 | $27.29 | $22K | 23,719 |
| 2021-08-12 | Helsel Dave SVP Global Operations and R&D | Option exercise · Performance Right | −6,945 | 0 | ||
| 2021-08-12 | Clemmer James C President and CEO | Option exercise | +19,387 | 378,554 | ||
| 2021-08-12 | Clemmer James C President and CEO | Shares withheld for taxes | −9,021 | $27.29 | $246K | 369,533 |
| 2021-08-12 | Clemmer James C President and CEO | Option exercise · Performance Right | −50,139 | 0 | ||
| 2021-08-12 | Campbell Chad Thomas SVP/GM, Vascular Access | Option exercise | +2,395 | 29,056 | ||
| 2021-08-12 | Campbell Chad Thomas SVP/GM, Vascular Access | Shares withheld for taxes | −702 | $27.29 | $19K | 28,354 |
| 2021-08-12 | Campbell Chad Thomas SVP/GM, Vascular Access | Option exercise · Performance Right | −6,195 | 0 | ||
| 2021-08-12 | Trowbridge Stephen A EVP and CFO | Option exercise | +3,231 | 71,539 | ||
| 2021-08-12 | Trowbridge Stephen A EVP and CFO | Shares withheld for taxes | −1,231 | $27.29 | $34K | 70,308 |
| 2021-08-12 | Trowbridge Stephen A EVP and CFO | Option exercise · Performance Right | −8,357 | 0 | ||
| 2021-07-28 | Meteny Dennis S Director | Option exercise | +5,726 | $14.64 | $84K | 117,865 |
Page 17 of 30 · 589 trades